Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data
This manuscript stresses the importance of RV in alleviating the burden of diarrhoeal diseases and associated costs in Uganda. The study not only emphasizes the tangible benefits derived from the vaccine but also highlights the role of routine aggregated healthcare information systems in systematically monitoring the effectiveness and coverage of interventions.
Authors
- Elizabeth Ekirapa Kiracho (ORCID: https://orcid.org/0000-0001-6938-2068)
- Bryan Patenaude (ORCID: https://orcid.org/0000-0002-5180-3626)
- Mutebi Aloysius (ORCID: https://orcid.org/0000-0002-6837-5488)
- Anthony Ssebagereka (ORCID: https://orcid.org/0000-0002-4061-2824)
- Gatien De Broucker (ORCID: https://orcid.org/0000-0001-6603-5124)
- Rornald Muhumuza Kananura (ORCID: https://orcid.org/0000-0002-9915-1989)
Institutions
- Johns Hopkins University (US)
- African Population and Health Research Center (KE)
- Innovations for Poverty Action (UG)
- Makerere University (UG)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1186/s12962-024-00586-5
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Johns Hopkins University
- Johns Hopkins Bloomberg School of Public Health